CD274 and breast cancer: We then assessed the impact of known biomarkers of immune response in breast cancer and solid tumors within TMB-H breast cancer and found that PD-L1 positivity and microsatellite instability were enriched in TMB-H tumors and predicted inflamed TMEs.